|
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
5.181e-78 |
1.00
|
| SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
1.483e-144 |
0.59
|
| ACES_MOUSE |
Ache |
Acetylcholinesterase |
2.945e-103 |
0.38
|
| CCR1_HUMAN |
CCR1 |
C-C chemokine receptor type 1 |
1.126e-101 |
0.50
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
4.488e-98 |
0.67
|
| SGMR1_MOUSE |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
9.507e-78 |
0.44
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
2.891e-74 |
0.59
|
| NPFF2_HUMAN |
NPFFR2 |
Neuropeptide FF receptor 2 |
4.267e-74 |
0.47
|
| NPFF1_HUMAN |
NPFFR1 |
Neuropeptide FF receptor 1 |
3.869e-73 |
0.47
|
| DRD3_CHLAE |
DRD3 |
D(3) dopamine receptor |
5.512e-71 |
0.59
|
| SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
1.849e-67 |
0.59
|
| DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
3.538e-67 |
0.44
|
| MCHR2_HUMAN |
MCHR2 |
Melanin-concentrating hormone receptor 2 |
4.415e-55 |
0.32
|
| SGMR2_RAT |
Tmem97 |
Sigma intracellular receptor 2 |
1.927e-53 |
0.51
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
2.076e-45 |
0.59
|
| DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
4.466e-44 |
0.59
|
| DRD2_CHLAE |
DRD2 |
D(2) dopamine receptor |
4.552e-44 |
0.59
|
| ACES_HUMAN |
ACHE |
Acetylcholinesterase |
9.578e-44 |
0.47
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
2.025e-42 |
0.55
|
| PAQR1_HUMAN |
ADIPOR1 |
Adiponectin receptor protein 1 |
2.89e-41 |
0.33
|
| PAQR2_HUMAN |
ADIPOR2 |
Adiponectin receptor protein 2 |
2.89e-41 |
0.33
|
| S6A12_HUMAN |
SLC6A12 |
Sodium- and chloride-dependent betaine transporter |
4.3e-41 |
0.39
|
| OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
7.289e-41 |
0.55
|
| S6A13_HUMAN |
SLC6A13 |
Sodium- and chloride-dependent GABA transporter 2 |
9.952e-40 |
0.31
|
| VACHT_TETCF |
|
Vesicular acetylcholine transporter |
4.592e-38 |
0.35
|
| S6A11_HUMAN |
SLC6A11 |
Sodium- and chloride-dependent GABA transporter 3 |
4.429e-36 |
0.39
|
| Q4CXF7_TRYCC |
|
Farnesyltransferase, putative |
9.362e-36 |
0.28
|
| UTS2_MACMU |
UTS2 |
Urotensin-2 |
1.377e-35 |
0.28
|
| DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
2.962e-35 |
0.59
|
| ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
4.168e-35 |
0.51
|
| ACES_RAT |
Ache |
Acetylcholinesterase |
7.528e-34 |
0.40
|
| US28_HCMVA |
US28 |
G-protein coupled receptor homolog US28 |
1.002e-32 |
0.50
|
| FAAH1_HUMAN |
FAAH |
Fatty-acid amide hydrolase 1 |
1.743e-32 |
0.43
|
| CCR8_HUMAN |
CCR8 |
C-C chemokine receptor type 8 |
1.035e-31 |
0.38
|
| ACM3_HUMAN |
CHRM3 |
Muscarinic acetylcholine receptor M3 |
6.243e-31 |
0.51
|
| BRS3_RAT |
Brs3 |
Bombesin receptor subtype-3 |
1.747e-30 |
0.29
|
| ZN664_CAVPO |
ZNF664 |
Zinc finger protein 664 |
1.607e-29 |
0.37
|
| ACES_ELEEL |
ache |
Acetylcholinesterase |
3.263e-28 |
0.40
|
| DRD1_BOVIN |
DRD1 |
D(1A) dopamine receptor |
4.963e-28 |
0.40
|
| NK2R_HUMAN |
TACR2 |
Substance-K receptor |
1.762e-27 |
0.40
|
| AMYP_PIG |
AMY2 |
Pancreatic alpha-amylase |
9.79e-26 |
0.31
|
| EBPL_HUMAN |
EBPL |
Emopamil-binding protein-like |
2.092e-25 |
0.41
|
| PA_I000X |
PA |
Polymerase acidic protein |
4.142e-23 |
0.45
|
| CP2D6_HUMAN |
CYP2D6 |
Cytochrome P450 2D6 |
1.852e-22 |
0.51
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
2.566e-21 |
0.40
|
| CHLE_HORSE |
BCHE |
Cholinesterase |
1.108e-20 |
0.38
|
| Q8VH26_CAVPO |
GPM3 |
Muscarinic acetylcholine receptor |
2.056e-20 |
0.43
|
| BACE1_MOUSE |
Bace1 |
Beta-secretase 1 |
3.883e-20 |
0.33
|
| VACHT_RAT |
Slc18a3 |
Vesicular acetylcholine transporter |
4.148e-20 |
0.47
|
| PDIA1_HUMAN |
P4HB |
Protein disulfide-isomerase |
4.726e-20 |
0.33
|
| NK2R_BOVIN |
TACR2 |
Substance-K receptor |
6.051e-20 |
0.38
|
| EBP_HUMAN |
EBP |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
6.855e-20 |
0.41
|
| VACHT_HUMAN |
SLC18A3 |
Vesicular acetylcholine transporter |
1.565e-19 |
0.41
|
| CHLE_HUMAN |
BCHE |
Cholinesterase |
1.566e-19 |
0.40
|
| H10_HUMAN |
H1-0 |
Histone H1.0 |
4.75e-19 |
0.37
|
| PA_I34A1 |
PA |
Polymerase acidic protein |
1.106e-18 |
0.45
|
| SSR5_HUMAN |
SSTR5 |
Somatostatin receptor type 5 |
1.494e-18 |
0.32
|
| NK1R_HUMAN |
TACR1 |
Substance-P receptor |
3.103e-18 |
0.46
|
| S6A13_MOUSE |
Slc6a13 |
Sodium- and chloride-dependent GABA transporter 2 |
5.892e-18 |
0.39
|
| MGLL_HUMAN |
MGLL |
Monoglyceride lipase |
1.737e-17 |
0.47
|
| SSR5_MOUSE |
Sstr5 |
Somatostatin receptor type 5 |
1.928e-17 |
0.31
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
1.952e-17 |
0.67
|
| VMAT2_RAT |
Slc18a2 |
Synaptic vesicular amine transporter |
3.76e-17 |
0.33
|
| NK2R_RAT |
Tacr2 |
Substance-K receptor |
4.118e-17 |
0.38
|
| LKHA4_MOUSE |
Lta4h |
Leukotriene A-4 hydrolase |
1.11e-16 |
0.42
|
| SC6A3_RAT |
Slc6a3 |
Sodium-dependent dopamine transporter |
3.331e-16 |
0.38
|
| CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
4.441e-16 |
0.46
|
| OGA_RAT |
Oga |
Protein O-GlcNAcase |
9.992e-16 |
0.35
|
| CALM_BOVIN |
CALM |
Calmodulin |
3.664e-15 |
0.42
|
| NMD3A_RAT |
Grin3a |
Glutamate receptor ionotropic, NMDA 3A |
4.996e-15 |
0.45
|
| S12A5_RAT |
Slc12a5 |
Solute carrier family 12 member 5 |
1.11e-14 |
0.35
|
| PLPL6_MOUSE |
Pnpla6 |
Neuropathy target esterase |
1.51e-14 |
0.35
|
| Q9HUN3_PSEAE |
dnaB |
Replicative DNA helicase |
2.187e-14 |
0.31
|
| P2RX4_MOUSE |
P2rx4 |
P2X purinoceptor 4 |
2.909e-14 |
0.42
|
| OPRM_RAT |
Oprm1 |
Mu-type opioid receptor |
3.098e-14 |
0.49
|
| HRH1_CAVPO |
HRH1 |
Histamine H1 receptor |
6.328e-14 |
0.41
|
| CXCR3_HUMAN |
CXCR3 |
C-X-C chemokine receptor type 3 |
1.019e-13 |
0.37
|
| HRH3_HUMAN |
HRH3 |
Histamine H3 receptor |
2.953e-13 |
0.42
|
| CASP5_HUMAN |
CASP5 |
Caspase-5 |
3.353e-13 |
0.38
|
| OPRX_MOUSE |
Oprl1 |
Nociceptin receptor |
4.846e-13 |
0.28
|
| DRD1_PIG |
DRD1 |
D(1A) dopamine receptor |
6.204e-13 |
0.37
|
| LKHA4_HUMAN |
LTA4H |
Leukotriene A-4 hydrolase |
1.888e-12 |
0.42
|
| HGFA_HUMAN |
HGFAC |
Hepatocyte growth factor activator |
1.928e-12 |
0.29
|
| P2RX4_RAT |
P2rx4 |
P2X purinoceptor 4 |
2.022e-12 |
0.42
|
| NK3R_CAVPO |
TACR3 |
Neuromedin-K receptor |
2.972e-12 |
0.31
|
| SC6A4_RAT |
Slc6a4 |
Sodium-dependent serotonin transporter |
3.047e-12 |
0.38
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
3.189e-12 |
0.68
|
| 5HT2A_RAT |
Htr2a |
5-hydroxytryptamine receptor 2A |
8.253e-12 |
0.51
|
| AL3A1_HUMAN |
ALDH3A1 |
Aldehyde dehydrogenase, dimeric NADP-preferring |
8.813e-12 |
0.37
|
| MGLL_MOUSE |
Mgll |
Monoglyceride lipase |
9.492e-12 |
0.35
|
| KCNK2_HUMAN |
KCNK2 |
Potassium channel subfamily K member 2 |
1.652e-11 |
0.37
|
| ABHD6_MOUSE |
Abhd6 |
Monoacylglycerol lipase ABHD6 |
2.022e-11 |
0.35
|
| LAT_MYCTU |
lat |
Probable L-lysine-epsilon aminotransferase |
2.335e-11 |
0.33
|
| Q6TUJ4_PSEAI |
blaIMP-1 |
Metallo beta-lactamase |
2.889e-11 |
0.43
|
| C3TDZ2_ECOLX |
fabH |
3-oxoacyl-[acyl-carrier-protein] synthase 3 |
3.242e-11 |
0.33
|
| 5HT1A_HUMAN |
HTR1A |
5-hydroxytryptamine receptor 1A |
4.675e-11 |
0.51
|
| OPRK_CAVPO |
OPRK1 |
Kappa-type opioid receptor |
4.993e-11 |
0.46
|
| AP2S1_RAT |
Ap2s1 |
AP-2 complex subunit sigma |
8.684e-11 |
0.37
|
| P2RX4_HUMAN |
P2RX4 |
P2X purinoceptor 4 |
1.006e-10 |
0.42
|
| SC6A4_MOUSE |
Slc6a4 |
Sodium-dependent serotonin transporter |
1.18e-10 |
0.30
|
| SCN4A_HUMAN |
SCN4A |
Sodium channel protein type 4 subunit alpha |
1.535e-10 |
0.33
|
| OPRD_RAT |
Oprd1 |
Delta-type opioid receptor |
3.151e-10 |
0.49
|
| FAAH1_RAT |
Faah |
Fatty-acid amide hydrolase 1 |
3.844e-10 |
0.40
|
| NMDE2_RAT |
Grin2b |
Glutamate receptor ionotropic, NMDA 2B |
4.757e-10 |
0.45
|
| HSP12_CAEEL |
hsp-16.2 |
Heat shock protein Hsp-16.2 |
5.162e-10 |
0.29
|
| ACHP_LYMST |
|
Acetylcholine-binding protein |
8.737e-10 |
0.53
|
| HEPS_HUMAN |
HPN |
Serine protease hepsin |
8.971e-10 |
0.33
|
| DRD5_HUMAN |
DRD5 |
D(1B) dopamine receptor |
9.104e-10 |
0.42
|
| Q4Q5W4_LEIMA |
|
Putative squalene synthase |
9.46e-10 |
0.28
|
| ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
1.041e-09 |
0.43
|
| DRD4_RAT |
Drd4 |
D(4) dopamine receptor |
1.554e-09 |
0.42
|
| GP183_HUMAN |
GPR183 |
G-protein coupled receptor 183 |
2.384e-09 |
0.37
|
| 5HT2A_BOVIN |
HTR2A |
5-hydroxytryptamine receptor 2A |
2.707e-09 |
0.39
|
| 5HT2A_PIG |
HTR2A |
5-hydroxytryptamine receptor 2A |
3.115e-09 |
0.37
|
| CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
3.454e-09 |
0.41
|
| ERG2_YEAST |
ERG2 |
C-8 sterol isomerase |
4.84e-09 |
0.37
|
| HRH3_RAT |
Hrh3 |
Histamine H3 receptor |
6.434e-09 |
0.39
|
| HRH2_HUMAN |
HRH2 |
Histamine H2 receptor |
6.617e-09 |
0.42
|
| P2RX1_HUMAN |
P2RX1 |
P2X purinoceptor 1 |
1.159e-08 |
0.42
|
| 5HT2C_RAT |
Htr2c |
5-hydroxytryptamine receptor 2C |
1.281e-08 |
0.39
|
| ACES_BOVIN |
ACHE |
Acetylcholinesterase |
1.661e-08 |
0.34
|
| BRS3_HUMAN |
BRS3 |
Bombesin receptor subtype-3 |
1.979e-08 |
0.29
|
| MALT1_HUMAN |
MALT1 |
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 |
2.795e-08 |
0.34
|
| MDR1_HUMAN |
ABCB1 |
ATP-dependent translocase ABCB1 |
3.407e-08 |
0.44
|
| CHKA_HUMAN |
CHKA |
Choline kinase alpha |
3.501e-08 |
0.37
|
| WNK1_HUMAN |
WNK1 |
Serine/threonine-protein kinase WNK1 |
3.985e-08 |
0.29
|
| SCN2A_RAT |
Scn2a |
Sodium channel protein type 2 subunit alpha |
7.25e-08 |
0.46
|
| ACM2_RAT |
Chrm2 |
Muscarinic acetylcholine receptor M2 |
1.091e-07 |
0.47
|
| KPYR_HUMAN |
PKLR |
Pyruvate kinase PKLR |
1.104e-07 |
0.30
|
| Q63380_RAT |
NET |
Transporter |
1.364e-07 |
0.37
|
| HRH3_CAVPO |
HRH3 |
Histamine H3 receptor |
1.383e-07 |
0.40
|
| CXCR4_HUMAN |
CXCR4 |
C-X-C chemokine receptor type 4 |
1.755e-07 |
0.36
|
| CARM1_HUMAN |
CARM1 |
Histone-arginine methyltransferase CARM1 |
1.797e-07 |
0.30
|
| NPSR1_HUMAN |
NPSR1 |
Neuropeptide S receptor |
2.009e-07 |
0.48
|
| S12A2_HUMAN |
SLC12A2 |
Solute carrier family 12 member 2 |
3.68e-07 |
0.31
|
| HRH1_RAT |
Hrh1 |
Histamine H1 receptor |
3.948e-07 |
0.42
|
| DHI1_RAT |
Hsd11b1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 |
4.46e-07 |
0.37
|
| MRP1_HUMAN |
ABCC1 |
Multidrug resistance-associated protein 1 |
5.351e-07 |
0.33
|
| ACES_TETCF |
ache |
Acetylcholinesterase |
5.729e-07 |
0.33
|
| HMOX2_RAT |
Hmox2 |
Heme oxygenase 2 |
6.901e-07 |
0.35
|
| 5HT7R_HUMAN |
HTR7 |
5-hydroxytryptamine receptor 7 |
7.746e-07 |
0.42
|
| Q9WTR4_RAT |
Slc6a2 |
Transporter |
8.271e-07 |
0.36
|
| ANM6_HUMAN |
PRMT6 |
Protein arginine N-methyltransferase 6 |
8.619e-07 |
0.30
|
| ACM3_RAT |
Chrm3 |
Muscarinic acetylcholine receptor M3 |
8.62e-07 |
0.34
|
| NMDE2_HUMAN |
GRIN2B |
Glutamate receptor ionotropic, NMDA 2B |
1.171e-06 |
0.41
|
| PRIO_SHEEP |
PRNP |
Major prion protein |
1.201e-06 |
0.31
|
| S6A12_MOUSE |
Slc6a12 |
Sodium- and chloride-dependent betaine transporter |
1.317e-06 |
0.31
|
| ADA1A_RABIT |
ADRA1A |
Alpha-1A adrenergic receptor |
1.323e-06 |
0.32
|
| LMBL3_HUMAN |
L3MBTL3 |
Lethal(3)malignant brain tumor-like protein 3 |
1.573e-06 |
0.34
|
| KCNA3_HUMAN |
KCNA3 |
Potassium voltage-gated channel subfamily A member 3 |
1.709e-06 |
0.50
|
| DRD1_RAT |
Drd1 |
D(1A) dopamine receptor |
2.284e-06 |
0.48
|
| MCHR1_HUMAN |
MCHR1 |
Melanin-concentrating hormone receptor 1 |
2.325e-06 |
0.40
|
| ACHA_TETCF |
CHRNA1 |
Acetylcholine receptor subunit alpha |
2.417e-06 |
0.33
|
| NMDZ1_HUMAN |
GRIN1 |
Glutamate receptor ionotropic, NMDA 1 |
2.528e-06 |
0.39
|
| ADA17_HUMAN |
ADAM17 |
Disintegrin and metalloproteinase domain-containing protein 17 |
2.584e-06 |
0.39
|
| 5HT2B_HUMAN |
HTR2B |
5-hydroxytryptamine receptor 2B |
2.977e-06 |
0.42
|
| PCP_HUMAN |
PRCP |
Lysosomal Pro-X carboxypeptidase |
4.776e-06 |
0.34
|
| FABP4_HUMAN |
FABP4 |
Fatty acid-binding protein, adipocyte |
5.186e-06 |
0.29
|
| OPRM_CAVPO |
OPRM1 |
Mu-type opioid receptor |
5.187e-06 |
0.42
|
| PGH2_SHEEP |
PTGS2 |
Prostaglandin G/H synthase 2 |
5.467e-06 |
0.33
|
| AADAT_HUMAN |
AADAT |
Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial |
6.654e-06 |
0.31
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
7.537e-06 |
0.42
|
| PPO2_AGABI |
PPO2 |
Polyphenol oxidase 2 |
9.54e-06 |
0.33
|
| PCP_MOUSE |
Prcp |
Lysosomal Pro-X carboxypeptidase |
9.945e-06 |
0.32
|
| ADA1B_RAT |
Adra1b |
Alpha-1B adrenergic receptor |
9.955e-06 |
0.42
|